The FDA’s recent decision to classify Laboratory-Developed Tests (LDTs) as medical devices has had a profound impact on the industry. In the absence of any passed legislation in 2022, the…
Read More
Commencing January 1, 2023, pathologists across the healthcare landscape gained access to a valuable arsenal of 13 new digital pathology add-on codes. These codes represent a significant milestone, brought to…
Lumea Inc., a leader in integrated digital pathology solutions, is pleased to announce our partnership with Invitae Corporation (Invitae), a leading medical genetics company. This partnership will give Lumea diagnostic…
We are so excited to attend upcoming conferences and events this fall for pathologists, pathologists’ assistants, urologists, histotechnologists, and many other professionals in the field of cancer diagnostics and medicine!...
Read More
Lumea Inc., a pioneer in global integrated digital pathology solutions, is thrilled to announce the second annual Digital Diagnostic Summit. This groundbreaking event will take place in the picturesque surroundings…
Welcome to our FAQ blog post about the Lumea FocalRing. We compiled a list of frequently asked questions about this technology so you can learn how it benefits pathology labs. …
